PD-L1 Checkpoint Blockade Delivered by Retroviral Replicating Vector Confers Anti-Tumor Efficacy in Murine Tumor Models
Oncotarget - United States
doi 10.18632/oncotarget.26785
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 19, 2019
Authors
Publisher
Impact Journals, LLC